Detalhe da pesquisa
1.
LAP: Liability Antibody Profiler by sequence & structural mapping of natural and therapeutic antibodies.
PLoS Comput Biol
; 20(3): e1011881, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-38442111
2.
Machine-designed biotherapeutics: opportunities, feasibility and advantages of deep learning in computational antibody discovery.
Brief Bioinform
; 23(4)2022 07 18.
Artigo
Inglês
| MEDLINE | ID: mdl-35830864
3.
Benchmarking antibody clustering methods using sequence, structural, and machine learning similarity measures for antibody discovery applications.
Front Mol Biosci
; 11: 1352508, 2024.
Artigo
Inglês
| MEDLINE | ID: mdl-38606289
4.
Large-scale data mining of four billion human antibody variable regions reveals convergence between therapeutic and natural antibodies that constrains search space for biologics drug discovery.
MAbs
; 16(1): 2361928, 2024.
Artigo
Inglês
| MEDLINE | ID: mdl-38844871
5.
Structural modeling of antibody variable regions using deep learning-progress and perspectives on drug discovery.
Front Mol Biosci
; 10: 1214424, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37484529